Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821476) titled 'Is Pain Ease (New Formula) Safe and Effective in Reducing Pain Associated With Peripheral Intravenous Cannulation (PIV)?' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Gebauer Company
Condition:
Peripheral Intravenous Cannulation
Pain Management
Intervention:
Other: Sterile water
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 2026
Target Sample Size: 100
Countries of Recruitment:
United State...